Evidence map›Paper›PMID 40622281›Full record

ArticleAnalytical chemistry2025

Fast and Accurate Charge State Deconvolution of Protein Mass Spectra.

Kenneth R Durbin, Matthew T Robey, Joseph B Greer, Ryan T Fellers, Aaron O Bailey

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenneth R DurbinProteinaceous, Inc., Evanston, Illinois 60201, United States.ORCID 0000-0001-7163-4877
Matthew T RobeyProteinaceous, Inc., Evanston, Illinois 60201, United States.ORCID 0000-0002-3596-9597
Joseph B GreerProteinaceous, Inc., Evanston, Illinois 60201, United States.
Ryan T FellersProteinaceous, Inc., Evanston, Illinois 60201, United States.
Aaron O BaileyAbCellera Biologics, Inc., Vancouver, British Columbia V5Y 1G6, Canada.ORCID 0000-0001-8063-3032

Funding

Data-Driven Software to Automate Top-Down Mass Spectrometry of Large MoleculesR44GM136046 · NIGMS · PROTEINACEOUS, INC. · PI DURBIN, KENNETH · 2023 to 2024
$1.9M
A comprehensive solution for native top down mass spectrometry data analyses across structural biology and biopharmaR44GM130262 · NIGMS · PROTEINACEOUS, INC. · PI DURBIN, KENNETH · 2022 to 2023
$1.6M
NIGMS NIH HHS R44 GM130262NIGMS NIH HHS R44 GM136046
6 · The paper itself

Abstract

Charge state deconvolution is essential for efficient and effective protein mass spectrometry analysis. High-quality mass profiling is necessary to determine which proteoforms are present in protein samples and their relative abundances. In the pursuit of a well-rounded deconvolution solution, we detail an iterative charge state deconvolution algorithm named kDecon that has been tuned to provide high accuracy in its mass results while also delivering superb sensitivity toward lower abundance proteoforms in complex spectra. Here, the performance of kDecon as a mass determination algorithm for both targeted antibody and high-throughput proteomics analysis was benchmarked against existing deconvolution solutions. While the different deconvolution routines all proved robust for detecting the highest abundance protein species, kDecon ultimately showcased best-in-class precision for lower abundance proteoform mass profiling. Furthermore, kDecon results had up to 7-fold fewer false positives and simultaneously exhibited at least 20-fold speed improvements over the other algorithms. Overall, these deconvolution advances will contribute to enabling both routine and thorough intact mass profiling studies for biotherapeutics as well as improving the proteome coverage of top-down proteomics experiments.

Indexed as

AlgorithmsMass SpectrometryProteinsProteomicsProteins

Identifiers

PMID40622281
PMCPMC12291047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.